Skip to main content
SpringerLink
Log in

Neutrophil gelatinase-associated lipocalin (NGAL) levels in twin pregnancy and association with gestational diabetes

  • Short Communication
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Zhu X, Huang C, Wu L et al (2022) Perinatal outcomes and related risk factors of single vs twin pregnancy complicated by gestational diabetes mellitus: meta-analysis. Comput Math Methods Med. https://doi.org/10.1155/2022/3557890

    Article  PubMed  PubMed Central  Google Scholar 

  2. Springer S, Franz M, Worda K, Gorczyca ME, Haslinger P, Worda C (2022) Neutrophil gelatinase-associated lipocalin and hypertensive disorders of pregnancy: a cohort study in twin pregnancies. J Clin Med 11(14):4163. https://doi.org/10.3390/jcm11144163

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Wang Y, Lam KS, Kraegen EW et al (2007) Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance and hyperglycemia in humans. Clin Chem 53(1):34–41. https://doi.org/10.1373/clinchem.2006.075614

    Article  CAS  PubMed  Google Scholar 

  4. Sisti G, Rubin G, Zhou C, Orth T, Schiattarella A (2023) Neutrophil gelatinase-associated lipocalin as a predictor of pre-eclampsia: a systematic review and meta-analysis. Int J Gynaecol Obstet 163(1):63–74. https://doi.org/10.1002/ijgo.14777

    Article  CAS  PubMed  Google Scholar 

  5. Lu L, Li C, Deng J, Luo J, Huang C (2022) Maternal serum NGAL in the first trimester of pregnancy is a potential biomarker for the prediction of gestational diabetes mellitus. Front Endocrinol (Lausanne) 16(13):977254. https://doi.org/10.3389/fendo.2022.977254

    Article  Google Scholar 

Download references

Acknowledgements

We would like to thank all subjects, doctors, researchers, and laboratory team for their cooperation and support.

Funding

The research reported in this publication was supported by Fondazione CRF Firenze Grant number B15F21003630007 to M.D.T.

Author information

Author notes

  1. Angela Silvano and Oumaima Ammar, Viola Seravalli and Mariarosaria Di Tommaso have equally contributed to this work.

Authors and Affiliations

  1. Division of Obstetrics and Gynecology, Department of Health Sciences, Careggi Hospital, University of Florence, Florence, Italy

    Angela Silvano, Oumaima Ammar, Noemi Strambi, Viola Seravalli & Mariarosaria Di Tommaso

  2. Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, College of Medicine, University of Arizona, Tucson, USA

    Giovanni Sisti

  3. Clinical Pharmacology and Oncology Section, Department of Health Sciences, University of Florence, Florence, Italy

    Astrid Parenti

Authors
  1. Angela Silvano
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Oumaima Ammar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Noemi Strambi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Giovanni Sisti
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Astrid Parenti
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Viola Seravalli
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mariarosaria Di Tommaso
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

AS contributed to Conceptualization, Methodology, Formal analysis, Investigation, Writing—original draft, Writing—review & editing. OA contributed to Methodology, Formal analysis, Investigation, Writing—original draft, Writing—review & editing. VS & AP contributed to Conceptualization, Methodology, Writing—review & editing. NS & GS contributed to Formal analysis, Resources, review & editing. MDT contributed to Conceptualization, Methodology, Supervision, Writing—review & editing.

Corresponding author

Correspondence to Viola Seravalli.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest.

Ethical standard statement

The study was approved by the Ethical Committee of Azienda Ospedaliero-Universitaria Careggi (Ref. No.10255/2017). All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008.

Informed consent

An informed consent was obtained from all patients for being included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article belongs to the topical collection Pregnancy and Diabetes, managed by Antonio Secchi and Marina Scavini.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Silvano, A., Ammar, O., Strambi, N. et al. Neutrophil gelatinase-associated lipocalin (NGAL) levels in twin pregnancy and association with gestational diabetes. Acta Diabetol (2024). https://doi.org/10.1007/s00592-024-02240-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00592-024-02240-1

Search

Navigation